Serum Institute seeks DCGI nod for phase2/3 trials of Oxford’s COVID-19 vaccine
According to the application, it would conduct an observer-blind, randomised controlled study to determine the safety and…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.